Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients...
Data Supports Routine Tumor Genotyping for Patients with Advanced Lung Cancers; May Improve Survival New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for...
View ArticleClik here to view.
OMNI-Connect Gets National Recognition as Valuable Social Media Solution in...
Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for both...
View ArticleChest Radiation Improves Survival in Extended-Stage Small Cell Lung Cancer
The results of a recently reported clinical study at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco demonstrate that thoracic radiation improves...
View ArticleInnovative Clinical Trials for Lung Cancer Currently Underway
The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for...
View ArticleClik here to view.
Changing the Face of Lung Cancer: Live Video Chat about Lung Cancer Screening...
Cancer screening saves lives, but when it comes to lung cancer, early detection has long been a challenge. Thankfully, the outlook for those at highest risk of this deadly disease is improving thanks...
View ArticleAdvanced Squamous Cell Lung Cancer: The Lung-MAP Trial
The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for...
View ArticleNFCR-Support Research Finds New Way to Combat Resistant Lung Cancer
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding...
View Article16th World Conference on Lung Cancer Expected to Highlight Advances in...
Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More...
View Article5 Things Women Should Know about Lung Cancer
By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the...
View ArticleSutent® Maintenance Therapy Found Active in Small-Cell Lung Cancer
Cancer Connect: Doctors have reported that maintenance therapy using Sutent® (sunitinib) delays the time to cancer progression and improves survival in patients with extensive-stage small-cell lung...
View ArticleLung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference
Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented progress in improving outcomes. Tailored treatments have...
View ArticleTwo-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients,...
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop...
View ArticleFirst Targeted Therapy Shows Promise in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 20–25% of all lung cancers. SCLC is an aggressive and fast-growing type of cancer that is very responsive to chemotherapy. However, although...
View ArticlePass It On: It’s National Lung Cancer Awareness Month
There are several types of lung cancer: non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma and lung carcinoid tumors, with NSCLC and SCLC accounting for about 95% of...
View ArticleKeytruda® Active in Small Cell Lung Cancer
Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer (SCLC) were recently presented at the 17th World Conference on...
View ArticleRecent Advances in The Management of Lung Cancer
The last 12 months continue to show advances in the treatment of non-small cell lung cancer (NSCLC), once again most notably in the sector of precision treatment. Importantly advances in the treatment...
View ArticleAdvanced Squamous Cell Lung Cancer: The Lung-MAP Trial
The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current […] The post Advanced Squamous Cell Lung Cancer: The Lung-MAP Trial...
View ArticleLung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference
Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented […] The post Lung Cancer Advances: Precision Medicine and...
View ArticleTwo-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients,...
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond […] The post Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer...
View ArticleFirst Targeted Therapy Shows Promise in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 20–25% of all lung cancers. SCLC is an aggressive and fast-growing type […] The post First Targeted Therapy Shows Promise in Small Cell Lung...
View Article